Research Article

A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Muscle-Invasive Bladder Cancer Patients after Partial Cystectomy

Table 2

Univariate and multivariate regression analyses for CSM.

CharacteristicsUnivariate analysisMultivariate analysis
HR (95% CI) valueHR (95% CI) value

Age
<60Ref.Ref.
60–701.311 (0.862–1.994)0.2061.143 (0.743–1.759)0.544
70–801.864 (1.249–2.782)0.0021.633 (1.075–2.479)0.021
>802.705 (1.841–3.975)<0.0012.289 (1.525–3.434)<0.001

Sex
FemaleRef.
Male0.926 (0.719–1.192)0.551

Race
WhiteRef.
Black1.081 (0.731–1.599)0.697
Others0.844 (0.529–1.346)0.476

Marital status
MarriedRef.
SDW1.267 (0.968–1.657)0.084
Single1.155 (0.804–1.659)0.436

Grade
Grade I or Grade IIRef.
Grade III or Grade IV1.891 (1.281–2.793)0.001

Histology
TCCRef.Ref.
SCC1.787 (1.183–2.699)0.0062.447 (1.537–3.894)<0.001
Adenocarcinoma0.440 (0.287–0.675)<0.0010.818 (0.468–1.428)0.479

T Stage
T2Ref.Ref.
T33.102 (2.309–4.168)<0.0013.395 (2.508–4.597)<0.001
T45.288 (3.586–7.798)<0.0013.956 (2.668–5.866)<0.001

N stage2.668–5.866
N0Ref.Ref.
N1 or N2 or N32.019 (1.449–2.813)<0.0012.277 (1.568–3.308)<0.001

M Stage
M0Ref.Ref.
M16.426 (4.030–10.247)<0.0014.872 (2.965–8.007)<0.001

Tumor size
<3 cmRef.Ref.
>3 cm1.475 (1.169–1.861)0.0011.334 (1.055–1.688)0.016

Number of tumor
SingleRef.
Multiple0.961 (0.756–1.223)0.749

Radiotherapy
No/unknownRef.Ref.
Yes1.379 (1.003–1.895)0.0481.059 (0.761–1.473)0.734

Chemotherapy
No/unknownRef.
Yes0.908 (0.710–1.162)0.444

Regional nodes examined
NonRef.Ref.
1–30.678 (0.522–0.879)0.0030.568 (0.396–0.815)0.002
>30.745 (0.540–1.029)0.0740.538 (0.406–0.713)<0.001

TCC: transitional cell carcinoma, SCC: squamous cell carcinoma; other races: American Indian, Alaska Native, Asian, and Pacific Islander; SDW: separated, divorced, or widowed; : statistical difference